Compared with conventional treatment of inotropes, which do not account for the subcellular localization of βARs and are known to cause oxidative injury and arrhythmias, restoring local catecholamines and subcellular adrenergic sensitivity may have considerable potential and advantages in treating heart diseases. Here, CTBP1 is linked to Arrhythmia.